Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Long-acting HIV drugs, a universal flu vaccine candidate, and a low-cost device in the fight against malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

The Financial Times highlights global successes and the remaining challenges in combating NTDs

In this guest post, Richard Hatzfeld, communications director for the Sabin Vaccine Institute, writes about a special report on neglected tropical diseases in the Financial Times, and the need for increased research, partnerships, and support to combat these diseases.

Sabin Vaccine Institute
Read More
PATH/Will Boase
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Celebrating the birthday of Breakthroughs: The best of the GHTC blog

It’s been a busy twelve months for the team at the Global Health Technologies Coalition!

GHTC
Read More
PATH/Dan Chang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Roundup: What will sweeping budget cuts do to health and research efforts?

Over the past few weeks—as Congress worked on a budget deal to keep the federal government running through the end of March 2013—several global health and international development groups released new reports about what looming, across-the-board cuts would do to these programs worldwide.

GHTC
Read More
PATH
Contraceptive R&D: neglected and in need of innovation

Today marks World Contraception Day, and there is much to celebrate about the successes of modern family planning.

Read More
PATH/Matthew Dakin
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Patrick McKern
The next chapter in the fight against neglected tropical diseases

In this guest post, Rachel Cohen—regional executive director of the Drugs for Neglected Diseases initiative (DNDi) North America—writes about the need for research to develop new health products for neglected tropical diseases (NTDs).

Read More
Update: White House releases budget report, House passes FY 2013 Continuing Resolution

Since our last update on the latest budget action on the Hill, two significant events happened late last week in Congress and at the White House.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
What’s ahead on the Hill

In this feature on Breakthroughs, we provide an update on what’s currently happening with global health in Congress and an outlook for future legislative activity.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
NIH program’s new leadership council lacks global health voices

Last week, the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) announced a key benchmark for the program—the formation of its new Advisory Council, which will meet for the first time later this month.

GHTC
Read More
PATH/Wendy Stone
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
What does the private sector really think about priority review vouchers?

In this guest post, Rianna Stefanakis—manager of Research and Policy at BIO Ventures for Global Health (BVGH)—writes about a new BVGH study this week in PLoS Neglected Tropical Diseases. This post originally appeared on the BVGH blog.

Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Why aren’t the candidates talking about R&D?

Next week marks a significant step in this year’s presidential elections, as Mitt Romney will become the official nominee for the Republican Party at its convention in Florida.

GHTC
Read More
PATH/Mike Wang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A global partnership for vaccine design

In this guest post, Margaret McGlynn, president & CEO of the International AIDS Vaccine Initiative (IAVI), writes about a new partnership between IAVI and the Indian government.

Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More